Treatment of HELLP syndrome with nitric oxide donor.
de Belder
A
A
Lees
C
C
Martin
J
J
Moncada
S
S
Campbell
S
S
D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D005978:Glutathione / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017359:HELLP Syndrome / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D009569:Nitric Oxide / Q000008:administration & dosage; D009603:Nitroso Compounds / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D010976:Platelet Count / Q000187:drug effects; D011247:Pregnancy; D026422:S-Nitrosoglutathione
D009603:Nitroso Compounds; D010975:Platelet Aggregation Inhibitors; D009569:Nitric Oxide; D026422:S-Nitrosoglutathione; D005978:Glutathione